Polaris Venture Partners Founders' Fund V, L.P.'s Net Worth
$0
Who is Polaris Venture Partners Founders' Fund V, L.P.?
Polaris Venture Partners Founders' Fund V, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Phreesia, Inc., BIND Therapeutics, Inc, Adagio Therapeutics, Inc., Cardlytics, Inc., Pulmatrix, Inc., OCULAR THERAPEUTIX, INC, FATE THERAPEUTICS INC, TREVENA INC, GENOCEA BIOSCIENCES, INC., SELECTA BIOSCIENCES INC, Cerulean Pharma Inc., Lyra Therapeutics, Inc., Kala Pharmaceuticals, Inc., T2 Biosystems, Inc., aTYR PHARMA INC, Arsanis, Inc., and INTERNET BRANDS, INC..
SEC CIK
Polaris Venture Partners Founders' Fund V, L.P.'s CIK is 0001439588
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Phreesia, Inc. (PHR) Snapshot price: $23.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.00% | -357.12K |
$24.48 | -$8,741,964.95 | 3.21M |
Dec 17
| |||
Form 4
|
∞
| 3.57M |
$18.00 | -$7,142,382.00 | 3.57M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIND Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.02M |
$15.00 |
—
| 2.02M |
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pulmatrix, Inc. (PULM) Snapshot price: $2.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.53% | 1.15M |
—
|
—
| 5.18M |
Apr 3
| |||
Form 4/A
| +2.72% | 74.04K |
$6.88 | $508,997.51 | 2.8M |
Jun 15
| |||
Form 4
| +7,856.20% | 4.03M |
$6.88 | $9,570.00 | 4.08M |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
TREVENA INC (TRVN) Snapshot price: $3.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.96% | -36.70K |
$6.04 | -$221,680.08 | 3.77M |
Aug 14
| |||
Form 4
| -0.15% | -5.70K |
$6.12 | -$34,884.00 | 3.81M |
Aug 13
| |||
Form 4
|
∞
| 3.81M |
$7.00 | $3,306,835.00 | 3.81M |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Lyra Therapeutics, Inc. (LYRA) Snapshot price: $0.2798
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +53.22% | 1.1M |
$14.16 | $999,969.16 | 3.17M |
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |